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Background: Stomatitis is a disturbing side-effect of chemotherapy that disturbs patients and causes difficulties in patient’s drinking, eating and talking, and may results in infection and bleeding.
Objectives: This study aimed to investigate the effect of Yarrow distillate in the treatment of chemotherapy-induced stomatitis.
Patients and Methods: This randomized controlled trial study was conducted during 2013. The study population consisted of all cancer patients with chemotherapy-induced oral stomatitis referred to Shahid Beheshti Medical Center, Kashan, Iran. The data collection instrument had two-part; a demographic part and another part recording the severity of the stomatitis at the first, seventh, and 14th days of the intervention based on a WHO criteria checklist in 2005. In this study, 56 patients diagnosed with cancer were randomly assigned into control and experimental groups in similar blocks according to their stomatitis severity. The experimental group gargled 15 mL of a routine solution mixed with Yarrow distillate 4 times a day for 14 days while the control group gargled 15 mL of routine solution. The severity of stomatitis was assessed at the beginning of the intervention, and then after 7 and 14 days of the study. Data were analyzed using chi-square and Fisher exact test, Mann-Whitney U, Kruskal-Wallis, and Friedman tests using SPSS 11.5 software.
Results: At first, the median score of stomatitis in the experimental group was 2.50 that significantly reduced to 1 and 0 in days 7 and 14 of the intervention, respectively (P value < 0.001). However, in the control group, the median score of stomatitis was 2.50, which significantly increased to 3 in days 7 and 14 (P value < 0.001).
Conclusions: Yarrow distillate-contained solution reduced stomatitis severity more than the routine solution. Therefore, we suggest using it in patients with chemotherapy-induced stomatitis.
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1. BackgroundCancer is an important challenge for the healthcare sys-tem (1, 2). Recent reports show that the rate of cancer is increasing with a fixed trend all over the world (1). Cancer has been known as the third major cause of mortality in Iran after the cardiovascular disease and accidents (3). Furthermore, it is the second cause of mortality in de-veloped countries (4), and accounts for 13% to 25% of all deaths worldwide (1, 5).Neoplasms are treated either to improve survival rate, or (if the treatment is impossible) to relief the symptoms, and to improve the quality of life. A combination of sur-gery, radiotherapy, chemotherapy, and biological treat-ments are usually used to achieve these objectives (2, 6). Chemotherapy is a common treatment that may result in longer periods of survival (7, 8). However, chemotherapy is accompanied with different problems; including bone marrow and immune system suppression; liver toxicity; complications in skin, central nervous system, urinary tract, and digestive tract such as inflammation of mouth and intestine mucosa (7, 8). Stomatitis or oral mucositis is a typical chemotherapy-induced debilitating problem (9, 10) to such an extent 
that about 10% of the patients receiving adjuvant chemo-therapy, 40% of the patients receiving neoadjuvant che-motherapy, and 80% of the patients being treated with stem cells suffer from this problem (11-13). Stomatitis-induced pain disturbs patients and makes it difficult to eat and drink, resulting in indigestion and dehydration (5, 9, 14). Stomatitis can also disturb speaking and com-munication with others, resulting in psychological and social problems (1, 7, 8). In addition, stomatitis is accom-panied by a wide range of oral mucosa alterations such as infection and bleeding, which could result in systemic infection (7, 8). In severe cases, it would increase the length of hospital-ization and even make the physician to cease the chemo-therapy (5, 9). Various methods and medications such as oral and dental hygiene, different types of mouthwash, applying ice and local anesthetics, magnesium-con-tained antacids, diphenhydramine, nystatin, prostaglan-din E, granulocyte-macrophage colony-stimulating fac-tor (GM-CSF), amphotericin, and chamomile essence are currently being used to treat stomatitis (2, 7, 8). Moreover, preventive measures are being taken, including receiv-
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ing baking soda, normal saline, chlorhexidine, sucralfate, persica solution, allopurinol mouthwash, menthe distil-late, and benzydamine solution (2, 7, 8, 15, 16). The most commonly used therapies often have no significant effect and sometimes cause additional problems (15). Given the side-effects of chemical drugs, complementary therapies in the forms of herbal products are increasingly used all over the world (17, 18). Most of the ancient civilizations used different forms of herbal medicines. The Yarrow plant (also called Ach-illea millefolium) belongs to the Asteraceae family. It is a well-known herb and has been extensively used in an-cient medicine for treating different diseases in general and burns and injuries in particular. One of the most important therapeutic effects of Yarrow plant is its anti-bacterial effect on a wide range of pathogens (19). The Yarrow fresh flowers have been used to treat respiratory problems (20). It was also employed as an anti-allergic (21), anti-congestion, and expectorant medicine (22). Its flowers’ distillates contain chamazulene, cineol, and borneol (23) with anti-inflammatory and anti-spasmodic effects (24, 25), and also beneficial effects on nervous, car-diovascular and digestive systems (21). Despite the historical background of this herb, reports about its therapeutic effects on wounds and injuries are rare (19). Aljancic et al. showed its significant inhibitory effect on Candida albicans and Bacillus subtilis in vitro. They also reported that, the flavonoids existed in Yarrow essence prevents the growth of Aspergillus niger (26). Sok-men et al. have also studied the antimicrobial effects of Yarrow distillate on 12 bacterial species and 2 types of yeast. They have reported that its aqueous extract had no antibacterial activity, the methanol one and the herb distillate had considerable antimicrobial activity though (27), in another study, no significant difference was ob-served in antimicrobial effects of aqueous and alcoholic extracts of Yarrow (19).
2. ObjectivesThe researchers’ observations showed that cancer pa-tients used Yarrow essence to alleviate their oral stomati-tis. Therefore, the present study was designed to investi-gate the effect of Yarrow distillate-contained solution on the chemotherapy-induced stomatitis.
3. Patients and MethodsThis was a triple-blind randomized trial study con-ducted on patients suffering from cancer with chemo-therapy-induced oral stomatitis referring to Shahid Be-heshti Hospital in Kashan, Iran, during 2013. They were under chemotherapy and received an anti-inflammatory drug (Dexamethasone 8 mg) as well. In this study, the patients, physician, and nurses (who gave the medica-tions) remained blind to the intervention outcomes and allocation of the subjects to the intervention and con-trol groups. The physician who examined patients’ oral 
mucosa was also blind to the study and the intervention groups. In addition, the statistician who performed the data analysis was kept blinded to the allocation, as well.Inclusion criteria were as follows: having chemother-apy-induced oral stomatitis; ≤ 20 years; complete con-sciousness; having no history of allergy, allergic rhinitis, and asthma; no history of radiotherapy; and not receiving systemic antibiotic and antifungal drugs. Exclusion crite-ria were receiving radiotherapy during the study, fever, use of another mouthwash during the study, patient’s de-cision to leave the study, irregular use of mouthwash in terms of time and amount, receiving systemic antibiotic or antifungal drugs at the beginning or during the study. The study sample size was calculated using the results of a local study conducted by Shabanloei et al. (2007), in which S1, S2, µ1, and µ2 were equal to 3.62, 6.95, 14.75, and 3.18, respectively. Accordingly, with a type I error of 0.05 and a power of 0.80, the sample size was determined to be seven patients for each group. However, for compen-sating probable attritions and achieving more reliable results, we enrolled 28 patients for each group. Patients were recruited to the study by using the convenience sampling method. In the present study, 56 patients were selected based on the above-mentioned criteria and were randomly assigned into control and experimental groups in similar blocks based on stomatitis intensity. No patient was excluded, and no data missed during the study (Figure 1).
3.1. InterventionThe routine mouthwash was prepared by adding 1400 mg of lidocaine, 224 mg of dexamethasone, 35000 mg of sucralfate per liter to diphenhydramine solution. The di-phenhydramine solution was purchased from Alborz Da-roo Company, Ghazvin, Iran. Control group received the routine mouthwash while the patients in the experimen-tal group received a mixture of the routing mouthwash and Yarrow distillate (50/50). Both bottles were similar in shape and size, distinguished only by a special code (bot-tle No. 1 and 2). The Yarrow  distillate was prepared from the yarrow herb growing in the plains of Ardahal, Kashan, Iran by Barij Esans Company, Kashan, Iran. In order to pre-pare 20 L of the distillate, 10 Kg of yarrow plant flowers with 50 L of water was boiled in a boiler connected to a condenser placed in cold water. The entire containers were from copper and the tubes from steel. The distillate used in this study had a concentration of 12 ppm.All patients were trained individually, how to do mouth care, and use toothbrush and mouthwash. The patients were trained to wash their hands four times a day (af-ter every meal: breakfast, lunch, dinner, and before go-ing to bed) and brush their teeth with a soft toothbrush and toothpaste. According to the instruction, for 14 days, they had to hold 15 mL of the solution for 3 minutes in their mouth and then discard it. They were not allowed to wash their mouth or eat for an hour after mouth
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Figure 1. Consort Flow Diagram
washing. To ensure proper mouthwash use, patients or one of their companions were trained to mark a check-list. The checklist had 14 columns (days) and each column with four rows (four times a day).
 3.2. Data CollectionThe data were collected using a two-part instrument. The first part consisted of demographic questions (age, gender, marital status, and education level), time of can-cer, chemotherapy information (type, cycle's number in before intervention and during the study), receiving an analgesic, smoking habit and artificial teeth. The second part of the instrument was a checklist used to record the severity of stomatitis at the first, seventh and 14th days of the experiment. The severity of stomatitis was assessed based on WHO criteria (2005) as follows: grade 0 (no wound); grade 1 (pain and erythema); grade 2 (erythema and wound, but the patient could swallow solid foods); grade 3 (wound and extensive erythema, in this case the patient could not eat solid foods); grade 4 (stomatitis has been spread to an extent that it could not be treated eas-ily and eating is impossible). The severity of stomatitis 
was scored according to its grade (i.e. ranging from 0 to 4). The content validity and reliability of the Persian ver-sion of checklist were confirmed by Ashktorab et al., and its inter-observer reliability was 0.93 (28).
3.3. Ethical ConsiderationsThe study was approved by the Research Council and Research Ethics Committee of Kashan University of Medi-cal Sciences, No. P/29/5/1/2571 dated 16 Sep. 2013. The objec-tives of the study were explained to all the participants, and all of them signed a written informed consent before participation in the study. All the patients were informed that participation in the study is voluntary and were as-sured that their personal information would be treated confidentially. Researchers were committed to consider the participants rights in accordance to the principles ex-plained in the Declaration of Helsinki.3.4. Data AnalysisData analysis was performed using SPSS version 11.5 software (SPSS Inc., Chicago, IL, and The USA). Descrip-tive statistics were used to describe and classify the data. Chi-square and Fisher exact tests were used to compare 
Miranzadeh S et al.
Nurs Midwifery Stud. 2014;3(3):e202494
the two groups in terms of gender, marital status, edu-cation level, time of cancer, smoking habit, using false teeth, number of chemotherapy cycles before interven-tion and during the study and receiving an analgesic drug. The Shapiro-Wilk test showed that the distribution of data was not normal. Friedman (in each group) and Mann-Whitney U tests (between two groups) were used 
to compare the stomatitis severity at three times: At the onset, 7, and 14 days after intervention. Also, the Mann-Whitney U test was used to compare the mean scores of stomatitis severity in the two genders.  The Spearman correlation coefficient was also used to evaluate the re-lationship between stomatitis severity and age. A P value less than 0.05 was considered significant for all tests.
Table 1. Demographic Information of the Cancer Patientsa
Variable Group P Value
Experimental Control
Gender 0.99b
Female 16 (57.1) 16 (57.1)
Male 12 (42.9) 12 (42.9)
Marital status 0.778b
Married 19 (67.9) 18 (64.3)
Single, Widow, Divorced 9 (32.1) 10 (35.7)
Education level 0.592b
Illiterate 14 (50) 12 (42.9)
Literate 14 (50) 16 (57.1)
Artificial teeth 0.99b
Yes 17 (60.7) 17 (60.7)
No 11 (39.3) 11 (39.3)
Smoking habit 0.485b
Yes 4 (14.3) 6 (21.4)
No 24 (85.7) 22 (78.6)
Duration of Cancer, mo 0.763c
< 12 21 (75) 20 (71.4)
> 12 7 (25)  8 (28.6)
Chemotherapy cycles before intervention 0.946c
1-5 times  9 (32.1)  9 (32.1)
5-10 times 15 (53.6) 13 (46.4)
10-15 times  1 (3.6) 2 (7.1)
15-20 times  3 ( 10.7)  4 (14.3)
Chemotherapy cycles during the study 0.567b
1 time 20 (71.4) 18 (64.3)
2 times 8 (28.6) 10 (35.7)
Receiving an Analgesic 0.99c
Yes 5 (17.8) 5 (17.8)
No 51 (82.2) 51 (82.2)a All data are presented as No. (%).b chi-square.c Fisher exact test.
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Figure 2. Comparison of the Severity of Stomatitis in Three Observations
Table 2. Comparison of Average Stomatitis Severity Scores in Three Observations
Severity of 
stomatitis
Group P Valuea Z Value
Control Experimental
Median (Q3-Q1) Median (Q3-Q1)
Before 
intervention
2.50 (3-2) 2.50 (3-2) 1 0.000
Day 7 after 
receiving 
mouthwash
3 (3-2) 1 (2-0) 0.001 -5.26
Day 14 after 
receiving 
mouthwash
3 (4-2) 0 (1-0) 0.001 -6.41
P valueb 0.001 0.001 - -a Mann-Whitney U test.b Friedman test.
4. ResultsTotally, 56 patients participated in this study. No sig-nificant difference was observed in terms of average age between the experimental (56.46 ± 14.32 y) and control group (55.54 ± 14.01 y) (P = 0.807). In total, 67.9% of the experimental group and 64.3% of the control group were married. There was no significant difference regarding false teeth, smoking habit, and other demographic infor-mation between the two groups (Table 1). The Spearman correlation coefficient showed no significant relation-ship between stomatitis severity and age (P value > 0.05). Also, the Mann-Whitney U test certified that gender had no effect on stomatitis severity before or during the study (P value > 0.05).Before receiving the solutions, 42.9% and 32.1% of the patients in control and experimental groups had grade 3 and 2 stomatitis, respectively (Figure 2). The median score of stomatitis severity was equal (2.50) in both groups at the start of the study. The median scores of stomatitis in the experimental group significantly reduced to 1 and 0 in days 7 and 14 after the intervention, respectively (P value < 0.001). However, in the control group, the median 
score of stomatitis increased to 3 in days 7 and 14 (P value < 0.001) (Table 2).
5. DiscussionThe present study was designed to investigate the effect of Yarrow distillate on chemotherapy-induced stomati-tis. In this study, the stomatitis severity was significantly reduced in the experimental group receiving the solu-tion contained Yarrow distillate. It was interesting to see that, more than 71% of the patients in this group were completely cured on 14th day of the experiment. Abedi-pour et al. have compared the effects of chlorhexidine and persica mouthwash -that contains A. millefolium- on preventing stomatitis in patients receiving chemother-apy and reported that both mouthwashes had similar effects. However, due to its better taste and smell, they recommended persica mouthwash as an alternative for chlorhexidine (7). Using different solutions and different forms of plant might be the reason for the different re-sults seen between their study and ours i.e. we used Yar-row distillate in our routine mouthwash, but they used the extract of Yarrow in chlorhexidine solution.  Rashidi et al. have shown that Yarrow distillate was ef-fective in treatment of rats’ gastric ulcer. This effect was attributed to the antibacterial and healing properties of Yarrow (29). Among herbal plants, Yarrow has gained at-tentions due to its wide range of therapeutic effects. It is a known herb, which has been used for thousands of years for treatment of different disorders, especially wounds and infections. Researches indicate that the essential oil of the herb has inhibitory effects on various bacteria (21, 25). According to Aljancic et al. (1999), the flavonoids in Yarrow essence have antifungal effect (26). Some flavo-noids (i.e. rutin, apigenin, luteolin, and acacetin) and bio-active ingredients of Yarrow essence (i.e. caffeic acid and salicylic acid) have antibacterial and anti-inflammatory effects (21, 25, 30). Sokmen et al. (2003) have extracted 32 separate ingredients from Yarrow, among which cam-phor and eucalyptol have significant inhibitory effects on Candida albicans and Clostridium perfringens. Also, borneol and piperitone in Yarrow essence are two other compounds with considerable bacterial inhibitory activ-ity (31). This antibacterial and anti-fungal effect of Yarrow might be one of the reasons for the results we had in our experiment. The routine mouthwash used in cancer clinic did not show any significant effect on the chemotherapy induced stomatitis in our study. In the present study, stomatitis severity increased in the control group during the experi-ment. In the control group, the number of the patients with grade 4 stomatitis increased from 7.1% to 21.4% on seventh and to 32.1% on 14th day of the experiment. The total percent of grade 3 and 4 was increased on seventh and 14th days of the experiment in control group as well. Clarkson et al. (2008), have reported that although allo-purinol, granulocyte growth factors, immunoglobulin and herbal extracts are effective but sucralfate, lidocaine, 
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or diphenhydramine had no effect in treating chemo-therapy-induced stomatitis (32).Since the mixture of Yarrow distillate with the routine solution used in this study could decrease the severity of stomatitis after chemotherapy and had no side effects, this solution might be used for all patients during che-motherapy. Given that the Yarrow distillate was mixed with ward’s routine solution, it is suggested that Yarrow distillate be used alone to clearly define its effect on sto-matitis improvement. Also the mixture of Yarrow distil-late with other types of mouthwash should be tested to optimize the effect of this plant.Some limitations are accounted for this study. For ex-ample, the patients took the solutions at home where the researcher had no control over them. Moreover, the small sample size, disregarding other variables such as teeth problems (decay, break, and implant), history of oral disease, and white blood cell (WBC) count may limit the generalizability of the findings. Also, it would be bet-ter if the patients’ mouths were checked daily in order to determine the treatment progress.
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